Arcus Biosciences Inc (RCUS) showcases a robust cash position and strategic collaborations, while navigating competitive ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

High cholesterol can cause the arteries to harden and narrow, making it more difficult for blood to flow. In some cases, it ...

ECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene insertion therapies for the treatment of liver disorders with significant unmet need, today announced ...

Community Healthcare Trust Incorporated (the "Company") today announced a key leadership change to extend the Company's operational momentum and increase focus on portfolio leasing, management, and ...

De La Salle University has one goal as the UAAP Esports Valorant Tournament resumes — retain the title in its hands.

Marcus (MCS) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.38 per share a year ago. These figures are adjusted ...

Shares of ThredUp Inc. TDUP rose sharply in today's pre-market trading after the company announced better-than-expected first ...

ECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene insertion therapies for the treatment of liver disorders with significant unmet need, today announced ...